StonvexLoading…
StonvexCore line items from DD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.86B | $1.68B | $6.85B | $1.79B | $1.75B |
Operating Income | Not available | $181.00M | $200.00M | $91.00M | $78.00M |
Net Income | Not available | $161.00M | $-779.00M | $-123.00M | $59.00M |
EPS (Diluted) | $0.61 | $0.39 | $-1.86 | $-0.29 | $0.14 |
Total Assets | Not available | $21.45B | $21.57B | $38.04B | $36.56B |
Total Liabilities | Not available | $7.21B | $7.47B | $14.70B | $13.04B |
Cash & Equivalents | Not available | $710.00M | $715.00M | $1.96B | $1.84B |
Free Cash Flow OCF − CapEx | Not available | $130.00M | $227.00M | $777.00M | $398.00M |
Shares Outstanding | Not available | 412.80M | 419.20M | 419.90M | 418.70M |